Cargando…

Synergic Effect of Metformin and Everolimus on Mitochondrial Dynamics of Renal Cell Carcinoma

Renal cell carcinoma (RCC) frequently recurs or metastasizes after surgical resection. Everolimus, an mTOR inhibitor, is used as a second-line treatment, but the response of RCC to everolimus is insufficient. Metformin is an antidiabetic drug; recent reports have indicated its anti-cancer effects in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Seong-Hwi, Lee, Kwang-Suk, Hwang, Hyun-Ji, Park, Sung-Yul, Han, Woong-Kyu, Yoon, Young-Eun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319793/ https://www.ncbi.nlm.nih.gov/pubmed/35885994 http://dx.doi.org/10.3390/genes13071211

Ejemplares similares

Ginsenoside Rh2 sensitizes the anti-cancer effects of sunitinib by inducing cell cycle arrest in renal cell carcinoma
por: Hwang, Hyun Ji, et al.
Publicado: (2022)

Inhibition of EZH2 exerts antitumorigenic effects in renal cell carcinoma via LATS1
por: Hong, Seong Hwi, et al.
Publicado: (2023)

Metformin and Everolimus: A Promising Combination for Neuroendocrine Tumors Treatment
por: Vitali, Eleonora, et al.
Publicado: (2020)

Effect of α1D-adrenoceptor blocker for the reduction of ureteral contractions
por: Hong, Seong Hwi, et al.
Publicado: (2023)

Metformin Potentiates the Anticancer Effect of Everolimus on Cervical Cancer In Vitro and In Vivo
por: Chen, Ya-Hui, et al.
Publicado: (2021)

Combined Use of Metformin and Everolimus Is Synergistic in the Treatment of Breast Cancer Cells
por: Wang, Yunshan, et al.
Publicado: (2015)

Metformin and erlotinib synergize to inhibit basal breast cancer
por: Lau, Ying-Ka Ingar, et al.
Publicado: (2014)

The use of everolimus in renal-transplant patients
por: Pascual, Julio
Publicado: (2009)

The Role of Everolimus in Renal Cell Carcinoma
por: Meskawi, Malek, et al.
Publicado: (2015)

A phase Ib study of everolimus combined with metformin for patients with advanced cancer
por: Molenaar, Remco J., et al.
Publicado: (2017)

Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation
por: Groenendijk, Floris H, et al.
Publicado: (2015)

Combination of Everolimus with Sorafenib for Solid Renal Tumors in Tsc2(+/−) Mice Is Superior to Everolimus Alone()
por: Yang, Jian, et al.
Publicado: (2017)

Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In Vivo
por: Mussin, Nadiar, et al.
Publicado: (2017)

Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells
por: Ariaans, Gerke, et al.
Publicado: (2017)

Role of everolimus in the treatment of renal cell carcinoma
por: George, Saby, et al.
Publicado: (2009)

Everolimus in Invasive Malignant Renal Epithelioid Angiomyolipoma
por: Guo, Gang, et al.
Publicado: (2021)

Glucose starvation induces resistance to metformin through the elevation of mitochondrial multidrug resistance protein 1
por: Hwang, Sung‐Hyun, et al.
Publicado: (2019)

Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
por: Wen, Kuo-Chang, et al.
Publicado: (2020)

Renoprotective Mechanism of Remote Ischemic Preconditioning Based on Transcriptomic Analysis in a Porcine Renal Ischemia Reperfusion Injury Model
por: Yoon, Young Eun, et al.
Publicado: (2015)

The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes
por: Chung, Hyun Hee, et al.
Publicado: (2013)

Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models
por: Valtorta, Silvia, et al.
Publicado: (2017)

Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker
por: Kim, Kwang Hyun, et al.
Publicado: (2019)

Everolimus – a new approach in the treatment of renal cell carcinoma
por: Anandappa, G, et al.
Publicado: (2010)

Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib
por: Serova, Maria, et al.
Publicado: (2016)

Immunological effects of everolimus in patients with metastatic renal cell cancer
por: Huijts, Charlotte M, et al.
Publicado: (2017)

Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma
por: Rossetti, Sabrina, et al.
Publicado: (2017)

Catheter-Related Bladder Discomfort: How Can We Manage It?
por: Jang, Eun Bi, et al.
Publicado: (2020)

The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma
por: Amirouchene-Angelozzi, Nabil, et al.
Publicado: (2016)

Early use of everolimus improved renal function after adult deceased donor liver transplantation
por: Lee, Seohee, et al.
Publicado: (2021)

Sirtuin 3 Activation by Honokiol Decreases Unilateral Ureteral Obstruction-Induced Renal Inflammation and Fibrosis via Regulation of Mitochondrial Dynamics and the Renal NF-κB-TGF-β1/Smad Signaling Pathway
por: Quan, Yi, et al.
Publicado: (2020)

Kaposi's Varicelliform-Like Eruption in a Patient Treated with Everolimus for Metastatic Renal Cell Carcinoma: Report of a Rare Case
por: Hong, Soojung, et al.
Publicado: (2014)

ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer
por: Kim, Eun Young, et al.
Publicado: (2017)

Vorolanib and everolimus: Lenvatinib and everolimus part deux, or something new?
por: Chehrazi-Raffle, Alexander, et al.
Publicado: (2020)

Clinical validation of serum endocan (ESM-1) as a potential biomarker in patients with renal cell carcinoma
por: Kim, Kwang Hyun, et al.
Publicado: (2017)

Functionalized Selenium Nanoparticles Synergizes With Metformin to Treat Breast Cancer Cells Through Regulation of Selenoproteins
por: Yang, Yu, et al.
Publicado: (2021)

Targeted therapies for renal cell carcinoma in Chinese patients: focus on everolimus
por: Tan, Xiaojie, et al.
Publicado: (2015)

Hypertension Caused by Lenvatinib and Everolimus in the Treatment of Metastatic Renal Cell Carcinoma
por: Bendtsen, Mathias Alrø Fichtner, et al.
Publicado: (2017)

Everolimus‐induced gastric antral vascular ectasia in advanced renal cancer
por: Hata, Kenichi, et al.
Publicado: (2020)

Increased risk of everolimus-associated acute kidney injury in cancer patients with impaired kidney function
por: Ha, Sung Hae, et al.
Publicado: (2014)

A Pharmacometabolomic Approach to Predict Response to Metformin in Early-Phase Type 2 Diabetes Mellitus Patients
por: Park, Jeong-Eun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6hlgnq5rupnpja0fgvqot3rht7